|
Book Title: Treating and Preventing Adolescent Mental Health Disorders
> pp. [656]
UNDEFINED: AUTHORS
Treating and Preventing Adolescent Mental Health Disorders
Print ISBN 9780195173642, 2005
pp. [656]
tions of genetic and perinatal factors. Archives of General Psychiatry, 50, 551–564.
Cannon-Spoor, H. E., Potkin, S. G., & Wyatt, R. J. (1982). Measurement of premorbid adjustment in chronic schizophrenia. Schizophrenia Bulletin, 8, 470–484.
Carpenter, W. T., Jr., Buchanan, R. W., Kirkpatrick, B., & Breier, A. F. (1999). Diazepam treatment of early signs of exacerbation in schizophrenia. American Journal of Psychiatry, 156, 299–303.
Caviness, V. S., Jr., Kennedy, D. N., Richelme, C., Rademacher, J., & Filipek, P. A. (1996). The human brain age 7–11 years: A volumetric analysis based on magnetic resonance images. Cerebral Cortex, 6, 726–736.
Chakos, M. H., Mayerhoff, D. I., Loebel, A. D., Alvir, J. M., & Lieberman, J. A. (1992). Incidence and correlates of acute extrapyramidal symptoms in first episode of schizophrenia. Psychopharmacological Bulletin, 28, 81–86.
Chouljian, T. L., Shumway, M., Balancio, E., Dwyer, E. V., Surber, R., & Jacobs, M. (1995). Substance use among schizophrenic outpatients: Prevalence, course, and relation to functional status. Annals of Clinical Psychiatry, 7, 19–24.
Chowdari, K. V., Mirnics, K., Semwal, P., Wood, J., Lawrence, E., Bhatia, T., et al. (2002). Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Human Molecular Genetics, 11, 1373–1380. 
Christison, G. W., Kirch, D. G., & Wyatt, R. J. (1991). When symptoms persist: Choosing among alternative somatic treatments for schizophrenia. Schizophrenia Bulletin, 17, 217–245.
Chumakov, I., Blumenfeld, M., Guerassimenko, O., Cavarec, L. Palicio, M., Abderrahim, H., et al. (2002). Genetic and physiological data implicating the new human gene G72 and the gene for d
-amino acid oxidase in schizophrenia. Proceeding of the National Academy of Science of the United States of America, 99, 13675–13680.
Clouston, T. S. (1892). Clinical lectures on mental diseases (3rd ed.) London: Churchill.
Cohen, R. (1990). Event-related potentials and cog
nitive dysfunction in schizophrenia. In H. Hafner, & W. Gattaz (Eds.), Search for the causes of schizophrenia (Vol. II, pp. 342–360). New York: Springer-Verlag.
Cohen, S., Lavelle, J., Rich, C. L., & Bromet, E. (1994). Rates and correlates of suicide attempts in first-admission psychotic patients. Acta Psychiatrica Scandinavica, 90, 167–171.
Cornblatt, B., Lenzenweger, M., Dworkin R., & Erlenmeyer-Kimling, L. (1992). Childhood attentional dysfunctions predict social deficits in unaffected adults at risk for schizophrenia. British Journal of Psychiatry, 161, 59–64.
Cosway, R., Byrne, M., Clafferty, R., Hodges, A., Grant, E., Abukmeil, S. S., et al. (2000). Neuropsychological change in young people at high risk for schizophrenia: Results from the first two neuropsychological assessments of the Edinburgh High-Risk Study. Psychological Medicine, 30, 1111–1121.
Crow, T. J., MacMillan, J. F., Johnson, A. L., & Johnstone, E. C. (1986). A randomized controlled trial of prophylactic neuroleptic treatment. British Journal of Psychiatry, 148, 120–127.
Cullberg, J. (1999). Integrating intensive psychosocial therapy and low-dose medical treatment in a total material of first-episode psychotic patients compared to “treatment as usual”—a 3-year follow-up. Medicinski Arhiv, 53, 167–170.
David, A. S., & Cutting, J. (1994). The neuropsychology of schizophrenia. Hove: Lawrence Erlbaum.
David, A. S., Malmberg, A., Brandt, L., Allebeck, P., & Lewis, G. (1997). IQ and risk for schizophrenia: A population-based cohort study. Psychological Medicine, 27, 1311–1323.
Davidson, M., Reichenberg, A., Rabinowitz, J., Weiser, M., Kaplan, Z., & Mark, M. (1999). Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. American Journal of Psychiatry, 156, 1328–1335.
end p.656
|
|
|
|
